Hrt Financial LP Accelerate Diagnostics, Inc Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.51 - $17.1 $6,594 - $221,120	12,931 New	12,931 $9,000
Q2 2022 Aug 12, 2022	BUY	$0.54 - $1.41 $47,370 - $123,689	87,723 Added 314.77%	115,592 $114,000
Q1 2022 May 16, 2022	BUY	$1.4 - $5.15 $9,646 - $35,483	6,890 Added 32.84%	27,869 $40,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $3,275 - $5,345	767 Added 3.79%	20,979 $109,000
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $107,325 - $166,749	20,212 New	20,212 $117,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $9.23 $83,579 - $113,279	-12,273 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.99 - $15.0 $49,330 - $92,610	-6,174 Reduced 33.47%	12,273 $102,000
Q4 2020 Feb 16, 2021	BUY	$7.04 - $11.7 $129,866 - $215,829	18,447 New	18,447 $139,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.